Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Upstream Bio Inc., 2 years.
Upstream Bio Inc.
Director
Kailera Therapeutics Inc.
Director · CEO & President
Chief executive roles
Kailera Therapeutics Inc.
· CEO & President
Since April 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | Kailera Therapeutics Inc. | Option exercise | +38,094 | $5.25 | $199,994 |
Questions about Ronald C. Renaud Jr.
What boards is Ronald C. Renaud Jr. on?
Ronald C. Renaud Jr. sits on the boards of Kailera Therapeutics Inc. and Upstream Bio Inc.
What company is Ronald C. Renaud Jr. the CEO of?
Ronald C. Renaud Jr. has been CEO & President of Kailera Therapeutics Inc. since April 2026.
How long has Ronald C. Renaud Jr. served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.